In a nutshell
This study aimed to compare two different treatments for benign prostatic hyperplasia (BPH). This study found that there was similar effectiveness between these treatment options for BPH.
Some background
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland. Photoselective vaporization of the prostate (PVP) can be used to treat BPH. This procedure uses a laser to remove prostate tissue that is blocking urine flow. This is known as Greenlight laser (GL.PVP). Another option is bipolar transurethral vaporization of the prostate (B.TUVP). This is a minimally invasive procedure in which a surgeon vaporizes excess prostate tissues blocking urine flow using a small, button-shaped tip.
It is unclear which is the better option for the treatment of medium size BPH.
Methods & findings
This study included 119 patients at the start of the study. Group A had GL.PVP. Group B had B.TUVP. Patients filled out questionnaires about their quality of life. They were followed up for 24 months.
There was a significant improvement in urinary symptoms in both groups in all follow-up visits. There was no significant difference in urinary symptoms between the two groups. Two years after surgery retreatment was needed in 13.8% of group A and 16.4% of group B. The cost of Group B treatment was much cheaper compared to group A.
The bottom line
This study found that there was no difference in effectiveness between GL.PVP and B.TUVP for BPH.
The fine print
Most men included in this analysis were not sexually active. Further studies are needed to evaluate the effect on the sexual function of these two treatment options.
Published By :
BJU international
Date :
Oct 16, 2019
